Notably, GPR158 expression was inversely correlated with β-secretase (BACE1) activity in AD brain samples, indicating that lower GPR158 levels are associated with increased BACE1 activity, which could in turn enhance Aβ production from Amyloid Precursor Protein (APP). Here, BACE1 is linked to Alzheimer disease.